Ikena Oncology (IKNA) Competitor Comparison
We are evaluating the key criteria listed to compare Ikena Oncology (IKNA) against its competitors in the Biotechnology industry.
Market Capitalization
280 / 368Gross Profits
196 / 278Total Revenue
175 / 300EBITDA
163 / 337Free Cashflow
190 / 352Quick Ratio
77 / 357Earnings per Share
170 / 359Dividend yield
0 / 6Total Cash
158 / 358Performance 3 years
297 / 368Performance 5 years
295 / 368Performance 10 years
260 / 368Linearity 3 years
269 / 368Linearity 5 years
290 / 368Linearity 10 years
260 / 368Total Rank
150 / 368Dividend Rank
154 / 368Valuation Rank
207 / 368Piotroski Rank
368 / 368Muliplier Rank
70 / 368EBITDA - IKNA ranking 163 / 337
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.